NASDAQ:AGIO - Agios Pharmaceuticals, Inc.
$42.91
 $-0.69
-1.58%
12:25PM EDT
2019-08-20
Agios Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group of over 600 rare genetic diseases caused by mutations, or defects, of single metabolic genes. The Company's cancer product candidates are enasidenib and ivosidenib (AG-120), which target mutated isocitrate dehydrogenase 2 (IDH2) and isocitrate dehydrogenase 1 (IDH1), respectively, and AG-881, which targets both mutated IDH1 and mutated IDH2. These mutations are found in a range of hematological malignancies and solid tumors. The lead product candidate in its rare genetic metabolic disorder (RGD), programs, AG-348, targets pyruvate kinase-R for the treatment of pyruvate kinase deficiency. Pyruvate kinase deficiency is a rare disorder that often results in severe hemolytic anemia due to inherited mutations in the pyruvate kinase enzyme within red blood cells. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  AGIO     avg for
industry  
  avg for
sector  
42 stocks weight:  171. 05   0. 00   0. 00  
42 stocks rank:  640. 00   1. 19 K 778. 64  
# analyst opinions:  9. 00   12. 89   13. 18  
mean recommendation:  2. 00   2. 12   2. 08  

quick ratio:  5. 70   5. 35   1. 96  
current ratio:  5. 96   5. 74   2. 49  

target price low:  52. 00   78. 50   109. 70  
target price avg:  80. 44   99. 04   132. 00  
target price high:  97. 00   125. 19   149. 83  
1-yr high:  83. 82   105. 14   135. 15  
last close:  43. 60   79. 13   117. 91  
50-day avg:  46. 39   79. 88   117. 98  
200-day avg:  54. 61   81. 87   114. 34  
1-yr low:  39. 27   62. 79   94. 47  
volume:  902. 59 K 3. 04 M 3. 86 M
50-day avg volume:  555. 27 K 3. 77 M 4. 23 M
200-day avg volume:  535. 46 K 3. 21 M 4. 70 M

1-day return:  2. 83 % 1. 53 % 0. 92 %
this week return:  2. 83 % 1. 53 % 0. 92 %
12-wk return:  -5. 57 % 5. 12 % 7. 51 %
52-wk return:  -44. 09 % -2. 50 % 4. 37 %

enterprise value (EV):  2. 12 B 42. 69 B 111. 80 B
market cap:  2. 56 B 37. 98 B 102. 40 B
EBITDA:  -399. 11 M 4. 69 B 7. 80 B
enterprise multiple (EV/EBITDA):  -5. 31   2. 31   10. 18  
enterprise/revenue (EV/R):  20. 84   65. 18   13. 32  
total revenue:  101. 66 M 10. 54 B 31. 92 B
total debt:  116. 47 M 11. 70 B 16. 96 B
debt/equity:  21. 86   246. 85   141. 66  
net income (common):  -389. 41 M 1. 83 B 3. 96 B

shares outstanding:  0. 00   565. 75 M 1. 25 B
shares:  51. 41 M 575. 65 M 1. 22 B
shares short:  9. 51 M 15. 48 M 13. 35 M
shares short prior month:  9. 08 M 11. 60 M 11. 95 M
short ratio:  18. 70   6. 99   3. 96  
short % of float:  37. 35 % 7. 01 % 2. 73 %
total cash/share:  8. 43   10. 36   9. 04  
total cash:  495. 39 M 6. 09 B 6. 03 B
free cash flow:  -178. 21 M 2. 85 B 4. 85 B
operating cash flow:  -329. 45 M 4. 03 B 5. 83 B

book value:  9. 07   13. 06   26. 64  
price/book:  4. 81   -0. 52   7. 05  
gross profits:  -248. 33 M 7. 98 B 35. 86 B
operating margins:  -400. 22 % -523. 06 % -116. 32 %
EBITDA margins:  0. 00 % 6. 67 % 24. 13 %
profit margins:  0. 00 % 2. 60 % 14. 46 %
gross margins:  -275. 15 % 39. 31 % 57. 94 %

1-yr max volatility:  13. 49 % --- ---
1-yr mean volatility:  2. 58 % 1. 94 % 1. 26 %

1-yr EPS:  -6. 67   1. 28   4. 09  
forward EPS:  -6. 95   3. 30   6. 68  
P/E:  -6. 53   16. 07   23. 47  
forward P/E:  -6. 10   4. 05   17. 87  
PE/G:  0. 19   1. 15   -1. 45  
growth:  -35. 10 % 235. 22 % 106. 28 %
earnings high:  -1. 34   1. 18   1. 62  
earnings avg:  -1. 77   0. 81   1. 50  
earnings low:  -1. 99   0. 52   1. 40  
revenue high:  65. 53 M 2. 83 B 8. 88 B
revenue avg:  35. 08 M 2. 74 B 8. 72 B
revenue low:  21. 60 M 2. 68 B 8. 54 B
return on assets:  -28. 54 % -2. 71 % 5. 57 %
return on equity:  -57. 44 % -25. 86 % 20. 65 %
revenue growth:  -35. 10 % 239. 32 % 44. 09 %
revenue/share:  1. 74   13. 07   53. 16  

beta (1yr vs S&P500):  1. 75   1. 23   0. 89  
sharpe (1yr):  -0. 74   0. 19   0. 58  

held % insiders:  12. 93 % 6. 64 % 3. 43 %
held % institutions:  102. 15 % 76. 64 % 67. 65 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-08-19 : AGIO
.    145.325 =         145.325 :: --> INITIAL WEIGHT <--
.    - 6.673 =         138.652 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.769 =         245.261 :: P/E factor
.    x 1.522 =         373.391 :: PE/G factor
.    x 1.647 =         614.801 :: beta factor
.    x 0.963 =         591.907 :: sharpe factor
.    x 2.266 =         1341.02 :: current ratio factor
.    x 0.889 =        1192.548 :: quick ratio factor
.    x 1.033 =        1231.568 :: short ratio factor
.    x 1.809 =        2228.004 :: EV/R factor
.    x 1.059 =        2360.409 :: price-to-book factor
.    x 0.982 =        2318.192 :: debt-to-revenue factor
.    x 2.291 =        5311.404 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.731 =       14506.096 :: sector+industry 1-year gains factor
.    x 1.051 =       15248.138 :: industry 12-weeks return factor
.    x 1.315 =       20045.233 :: industry 2-weeks return factor
.    x 0.963 =       19302.279 :: company one-year gains+dividend factor
.    x 3.072 =       59293.899 :: company 13 weeks' performance factor
.    x 0.999 =       59244.278 :: "drift" penalty 5 days ago
.    x 0.931 =       55160.265 :: overall "drift" factor
.    x 0.905 =       49915.627 :: largest single-day price delta factor
.    x 0.996 =       49734.308 :: volatility factor
.    x 0.997 =       49579.256 :: 42-day volatility factor
.    x 4.968 =      246303.223 :: notable returns + performance factor
.    x 2.163 =      532785.422 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.     x 1.38 =      735137.034 :: forward P/E factor
.    x 1.183 =      869304.962 :: industry recommendation factor
.     x 2.22 =      1929629.73 :: company recommendation factor
.    x 1.019 =     1967165.625 :: factor historical industry gain for week 33
.    x 1.545 =     3038463.644 :: target low factor
.    x 1.306 =     3969462.946 :: target mean factor
.    x 1.046 =     4153968.068 :: target high factor
.    x 8.465 =     35162171.75 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =          77.005 :: reduced for readability
.   + 94.044 =         171.049 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                    171.049 :: FINAL WEIGHT for NASDAQ:AGIO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org